Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Sustained elevations of S100B have been reported in the patients with large brain infarcts (25)
With further research, it is expected to transform from a research tool into a clinical drug, filling the niche in targeted metabolic therapy, especially in the combined intervention of obesity and type 2 diabetes, where it holds unique application potential
-
Its application has been studied extensively in clinical settings, especially for those dealing with obesity or insulin resistance
All patients were closely tracked for up to 5 years for any occurrence of the outcome of interests
US$ 19.99
US$ 27.73
US$ 27.11
US$ 24.54
US$ 24.52
